ODOB > Events > Analysing the Evidence: Atropine in Myopia Progression

Analysing the Evidence: Atropine in Myopia Progression

Date: Wed 05/05/2021 - Fri 05/05/2023

Provider: Centre For Eye Health

Optometrist Credits: 1 General Credit

Event Type(s): Online

Contact


The prevalence of myopia is increasing worldwide. Due to associated sight-threatening ocular pathologies, myopia is recognised as a public health burden. Various interventions to slow down or stop the progression of childhood myopia, to reduce the risk of blindness later in life, have been investigated. Currently, atropine is considered one of the most effective treatments to control myopia progression. This presentation will discuss clinical trials of atropine on myopia progression in children and clinical considerations when prescribing atropine in clinical practice.

Log this activity to my CPD

Location

This event does not have a physical location